|
07 Jan 2023 |
Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US
|
|
06 Jan 2023 |
Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech
|
|
06 Jan 2023 |
Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
|
|
04 Jan 2023 |
NorthStar Medical Radioisotopes and Inhibrx Enter into Collaboration Agreement for the Development and Production of Radiopharmaceutical Candidates
|
|
04 Jan 2023 |
Belharra Therapeutics Announces Broad Collaboration with Genentech to Discover and Develop Novel Medicines Across Multiple Therapeutic Areas
|
|
04 Jan 2023 |
Biogen and Alcyone Therapeutics Announce License and Collaboration Agreement to Evaluate a Novel Device to Improve Patient Experience and Access to Neurological ASO Therapies
|
|
03 Jan 2023 |
Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies
|
|
02 Jan 2023 |
Alteogen Enters Into an Exclusive License Agreement to Develop and Commercialize Biosimilar Products Enabled by Alteogen’s Hybrozyme™ Technology
|
|
28 Dec 2022 |
PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates
|
|
28 Dec 2022 |
PeptiDream Announces New Research and Collaboration Agreement with Lilly for the Discovery of Novel Peptide Drug Conjugates
|
|
24 Dec 2022 |
LegoChem Biosciences and Amgen Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates
|
|
22 Dec 2022 |
Merck and Kelun-Biotech Announce Exclusive License and Collaboration Agreement for Seven Investigational Antibody-drug Conjugate Candidates for the Treatment of Cancer
|
|
22 Dec 2022 |
Lilly and ProQR to Expand RNA Editing Collaboration
|
|
20 Dec 2022 |
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
|
|
19 Dec 2022 |
Sanofi and Innate Pharma Expand Collaboration for Natural Killer Cell Therapeutics in Oncology
|
|
15 Dec 2022 |
GSK and Wave Life Sciences announce collaboration to drive discovery and development of oligonucleotide therapeutics focusing on novel genetic targets
|
|
15 Dec 2022 |
Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators
|
|
15 Dec 2022 |
Arthex announces regulatory milestones met in its program to develop ATX-01 in Myotonic Dystrophy Type 1
|
|
15 Dec 2022 |
Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease
|
|
14 Dec 2022 |
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
|
|
12 Dec 2022 |
Amgen Inc to Acquire Horizon Therapeutics plc
|
|
08 Dec 2022 |
Vertex and Entrada Therapeutics Establish Collaboration to Discover and Develop Endosomal Escape Vehicle (EEV) Therapeutics for Myotonic Dystrophy Type 1 (DM1)
|
|
07 Dec 2022 |
MorphoSys Out Licenses Pre-Clinical Oncology Program
|
|
06 Dec 2022 |
Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy
|
|
06 Dec 2022 |
Equillium and Ono Pharmaceutical Announce Exclusive Option and Asset Purchase Agreement for the Development and Commercialization of Itolizumab
|
